Cargando…

Effective heating of magnetic nanoparticle aggregates for in vivo nano-theranostic hyperthermia

Magnetic resonance (MR) nano-theranostic hyperthermia uses magnetic nanoparticles to target and accumulate at the lesions and generate heat to kill lesion cells directly through hyperthermia or indirectly through thermal activation and control releasing of drugs. Preclinical and translational applic...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Chencai, Hsu, Chao-Hsiung, Li, Zhao, Hwang, Lian-Pin, Lin, Ying-Chih, Chou, Pi-Tai, Lin, Yung-Ya
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5584909/
https://www.ncbi.nlm.nih.gov/pubmed/28894366
http://dx.doi.org/10.2147/IJN.S141072
_version_ 1783261525258010624
author Wang, Chencai
Hsu, Chao-Hsiung
Li, Zhao
Hwang, Lian-Pin
Lin, Ying-Chih
Chou, Pi-Tai
Lin, Yung-Ya
author_facet Wang, Chencai
Hsu, Chao-Hsiung
Li, Zhao
Hwang, Lian-Pin
Lin, Ying-Chih
Chou, Pi-Tai
Lin, Yung-Ya
author_sort Wang, Chencai
collection PubMed
description Magnetic resonance (MR) nano-theranostic hyperthermia uses magnetic nanoparticles to target and accumulate at the lesions and generate heat to kill lesion cells directly through hyperthermia or indirectly through thermal activation and control releasing of drugs. Preclinical and translational applications of MR nano-theranostic hyperthermia are currently limited by a few major theoretical difficulties and experimental challenges in in vivo conditions. For example, conventional models for estimating the heat generated and the optimal magnetic nanoparticle sizes for hyperthermia do not accurately reproduce reported in vivo experimental results. In this work, a revised cluster-based model was proposed to predict the specific loss power (SLP) by explicitly considering magnetic nanoparticle aggregation in in vivo conditions. By comparing with the reported experimental results of magnetite Fe(3)O(4) and cobalt ferrite CoFe(2)O(4) magnetic nanoparticles, it is shown that the revised cluster-based model provides a more accurate prediction of the experimental values than the conventional models that assume magnetic nanoparticles act as single units. It also provides a clear physical picture: the aggregation of magnetic nanoparticles increases the cluster magnetic anisotropy while reducing both the cluster domain magnetization and the average magnetic moment, which, in turn, shift the predicted SLP toward a smaller magnetic nanoparticle diameter with lower peak values. As a result, the heating efficiency and the SLP values are decreased. The improvement in the prediction accuracy in in vivo conditions is particularly pronounced when the magnetic nanoparticle diameter is in the range of ~10–20 nm. This happens to be an important size range for MR cancer nano-theranostics, as it exhibits the highest efficacy against both primary and metastatic tumors in vivo. Our studies show that a relatively 20%–25% smaller magnetic nanoparticle diameter should be chosen to reach the maximal heating efficiency in comparison with the optimal size predicted by previous models.
format Online
Article
Text
id pubmed-5584909
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Dove Medical Press
record_format MEDLINE/PubMed
spelling pubmed-55849092017-09-11 Effective heating of magnetic nanoparticle aggregates for in vivo nano-theranostic hyperthermia Wang, Chencai Hsu, Chao-Hsiung Li, Zhao Hwang, Lian-Pin Lin, Ying-Chih Chou, Pi-Tai Lin, Yung-Ya Int J Nanomedicine Original Research Magnetic resonance (MR) nano-theranostic hyperthermia uses magnetic nanoparticles to target and accumulate at the lesions and generate heat to kill lesion cells directly through hyperthermia or indirectly through thermal activation and control releasing of drugs. Preclinical and translational applications of MR nano-theranostic hyperthermia are currently limited by a few major theoretical difficulties and experimental challenges in in vivo conditions. For example, conventional models for estimating the heat generated and the optimal magnetic nanoparticle sizes for hyperthermia do not accurately reproduce reported in vivo experimental results. In this work, a revised cluster-based model was proposed to predict the specific loss power (SLP) by explicitly considering magnetic nanoparticle aggregation in in vivo conditions. By comparing with the reported experimental results of magnetite Fe(3)O(4) and cobalt ferrite CoFe(2)O(4) magnetic nanoparticles, it is shown that the revised cluster-based model provides a more accurate prediction of the experimental values than the conventional models that assume magnetic nanoparticles act as single units. It also provides a clear physical picture: the aggregation of magnetic nanoparticles increases the cluster magnetic anisotropy while reducing both the cluster domain magnetization and the average magnetic moment, which, in turn, shift the predicted SLP toward a smaller magnetic nanoparticle diameter with lower peak values. As a result, the heating efficiency and the SLP values are decreased. The improvement in the prediction accuracy in in vivo conditions is particularly pronounced when the magnetic nanoparticle diameter is in the range of ~10–20 nm. This happens to be an important size range for MR cancer nano-theranostics, as it exhibits the highest efficacy against both primary and metastatic tumors in vivo. Our studies show that a relatively 20%–25% smaller magnetic nanoparticle diameter should be chosen to reach the maximal heating efficiency in comparison with the optimal size predicted by previous models. Dove Medical Press 2017-08-28 /pmc/articles/PMC5584909/ /pubmed/28894366 http://dx.doi.org/10.2147/IJN.S141072 Text en © 2017 Wang et al. This work is published and licensed by Dove Medical Press Limited The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed.
spellingShingle Original Research
Wang, Chencai
Hsu, Chao-Hsiung
Li, Zhao
Hwang, Lian-Pin
Lin, Ying-Chih
Chou, Pi-Tai
Lin, Yung-Ya
Effective heating of magnetic nanoparticle aggregates for in vivo nano-theranostic hyperthermia
title Effective heating of magnetic nanoparticle aggregates for in vivo nano-theranostic hyperthermia
title_full Effective heating of magnetic nanoparticle aggregates for in vivo nano-theranostic hyperthermia
title_fullStr Effective heating of magnetic nanoparticle aggregates for in vivo nano-theranostic hyperthermia
title_full_unstemmed Effective heating of magnetic nanoparticle aggregates for in vivo nano-theranostic hyperthermia
title_short Effective heating of magnetic nanoparticle aggregates for in vivo nano-theranostic hyperthermia
title_sort effective heating of magnetic nanoparticle aggregates for in vivo nano-theranostic hyperthermia
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5584909/
https://www.ncbi.nlm.nih.gov/pubmed/28894366
http://dx.doi.org/10.2147/IJN.S141072
work_keys_str_mv AT wangchencai effectiveheatingofmagneticnanoparticleaggregatesforinvivonanotheranostichyperthermia
AT hsuchaohsiung effectiveheatingofmagneticnanoparticleaggregatesforinvivonanotheranostichyperthermia
AT lizhao effectiveheatingofmagneticnanoparticleaggregatesforinvivonanotheranostichyperthermia
AT hwanglianpin effectiveheatingofmagneticnanoparticleaggregatesforinvivonanotheranostichyperthermia
AT linyingchih effectiveheatingofmagneticnanoparticleaggregatesforinvivonanotheranostichyperthermia
AT choupitai effectiveheatingofmagneticnanoparticleaggregatesforinvivonanotheranostichyperthermia
AT linyungya effectiveheatingofmagneticnanoparticleaggregatesforinvivonanotheranostichyperthermia